Detalles de la búsqueda
1.
COVID-19 therapeutics: Challenges and directions for the future.
Proc Natl Acad Sci U S A
; 119(15): e2119893119, 2022 04 12.
Artículo
en Inglés
| MEDLINE | ID: mdl-35385354
2.
COVID-19 vaccine hesitancy in inflammatory arthritis patients: serial surveys from a large longitudinal national Australian cohort.
Rheumatology (Oxford)
; 62(4): 1460-1466, 2023 04 03.
Artículo
en Inglés
| MEDLINE | ID: mdl-36069664
3.
Gout and the COVID-19 pandemic.
Curr Opin Rheumatol
; 34(2): 111-117, 2022 03 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-34907115
4.
Temporal trends in COVID-19 outcomes in people with rheumatic diseases in Ireland: data from the COVID-19 Global Rheumatology Alliance registry.
Rheumatology (Oxford)
; 61(SI2): SI151-SI156, 2022 06 28.
Artículo
en Inglés
| MEDLINE | ID: mdl-35258593
5.
Inhibiting IL-17A and IL-17F in Rheumatic Disease: Therapeutics Help to Elucidate Disease Mechanisms.
Curr Rheumatol Rep
; 24(10): 310-320, 2022 10.
Artículo
en Inglés
| MEDLINE | ID: mdl-35861937
6.
Global research collaboration in a pandemic-challenges and opportunities: the COVID-19 Global Rheumatology Alliance.
Curr Opin Rheumatol
; 33(2): 111-116, 2021 03 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-33394601
7.
Coronavirus disease 2019: update on coronavirus disease 2019 outcomes and vaccine efficacy in patients with immune-mediated inflammatory disease.
Curr Opin Rheumatol
; 33(5): 412-418, 2021 09 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-34171857
8.
Factors associated with COVID-19-related death in people with rheumatic diseases: results from the COVID-19 Global Rheumatology Alliance physician-reported registry.
Ann Rheum Dis
; 80(7): 930-942, 2021 07.
Artículo
en Inglés
| MEDLINE | ID: mdl-33504483
9.
The COVID-19 Global Rheumatology Alliance: evaluating the rapid design and implementation of an international registry against best practice.
Rheumatology (Oxford)
; 60(1): 353-358, 2021 01 05.
Artículo
en Inglés
| MEDLINE | ID: mdl-32789449
10.
Value-Based Healthcare in Rheumatology: Axial Spondyloarthritis and Beyond.
Curr Rheumatol Rep
; 23(6): 36, 2021 04 28.
Artículo
en Inglés
| MEDLINE | ID: mdl-33909169
11.
Healthcare access and attitudes towards telehealth during the early phase of the COVID-19 pandemic among an Australian cohort with inflammatory arthritis.
Intern Med J
; 51(5): 788-792, 2021 05.
Artículo
en Inglés
| MEDLINE | ID: mdl-34047040
12.
Epidemiology and outcomes of novel coronavirus 2019 in patients with immune-mediated inflammatory diseases.
Curr Opin Rheumatol
; 32(5): 434-440, 2020 09.
Artículo
en Inglés
| MEDLINE | ID: mdl-32675715
13.
Characteristics associated with hospitalisation for COVID-19 in people with rheumatic disease: data from the COVID-19 Global Rheumatology Alliance physician-reported registry.
Ann Rheum Dis
; 79(7): 859-866, 2020 07.
Artículo
en Inglés
| MEDLINE | ID: mdl-32471903
14.
Management of patients with gout and achievement of target serum urate levels at a tertiary rheumatology service in Australia.
Intern Med J
; 50(3): 337-341, 2020 03.
Artículo
en Inglés
| MEDLINE | ID: mdl-31386267
15.
Response to: Correspondence on "Associations of baseline use of biologic or targeted synthetic DMARDs with COVID-19 severity in rheumatoid arthritis: results from the COVID-19 Global Rheumatology Alliance physician registry" by Sparks et al.
Ann Rheum Dis
; 82(7): e158, 2023 07.
Artículo
en Inglés
| MEDLINE | ID: mdl-34426400
16.
Response to: Correspondence on "Associations of baseline use of biologic or targeted synthetic DMARDs with COVID-19 severity in rheumatoid arthritis" by van Vollenhoven et al.
Ann Rheum Dis
; 82(8): e178, 2023 Aug.
Artículo
en Inglés
| MEDLINE | ID: mdl-34389604
17.
Response to: 'Correspondence on 'Factors associated with COVID-19-related death in people with rheumatic diseases: results from the COVID-19 Global Rheumatology Alliance physician reported registry'' by Rosenbaum et al.
Ann Rheum Dis
; 82(6): e139, 2023 06.
Artículo
en Inglés
| MEDLINE | ID: mdl-33985941
18.
Response to: 'Correspondence on 'Factors associated with COVID-19-related death in people with rheumatic diseases: results from the COVID-19 Global Rheumatology Alliance physician reported registry' by Arnaud and Devilliers.
Ann Rheum Dis
; 82(5): e114, 2023 05.
Artículo
en Inglés
| MEDLINE | ID: mdl-33602795
19.
Response to: 'Correspondence on 'Factors associated with COVID-19-related death in people with rheumatic diseases: results from the COVID-19 Global Rheumatology Alliance physician reported registry'' by Mulhearn et al.
Ann Rheum Dis
; 82(5): e116, 2023 05.
Artículo
en Inglés
| MEDLINE | ID: mdl-33648957
20.
Rheumatic disease activity, glucocorticoid use and COVID-19. Response to: 'Correspondence on 'Characteristics associated with hospitalisation for COVID-19 in people with rheumatic disease: data from the COVID-19 Global Rheumatology Alliance physician-reported registry' by Gianfrancesco et al. Disease activity, rather than glucocorticoid therapy, may be associated with COVID-19 severity in patients with rheumatic musculoskeletal diseases' by Giollo et al.
Ann Rheum Dis
; 81(11): e223, 2022 11.
Artículo
en Inglés
| MEDLINE | ID: mdl-32895239